NULISAseq CNS Disease Panel 120 Expanded with Blood-Based Brain-Derived pTau AssaysÂ
Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.
Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.
Researchers developed a surgical face mask embedded with a breath sensor that can non-invasively detect chronic kidney disease (CKD).
Due to climate change, wilderness encroachment, and better diagnoses, AGS has joined a growing list of both tick-borne & allergic diseases.
Mursla Bio has received FDA Breakthrough Device Designation for EvoLiver, a novel blood test using Dynamic Biopsy technology.
The Oropouche virus, once thought rare, is now recognized as widely underdiagnosed in Latin America, and needs more research.
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
One-Sentence Summary:Beckman Coulter Life Sciences has launched a next-generation Basophil...
Researchers have successfully adapted high-field NMR-based lipoprotein analysis to cost-effective benchtop NMR systems.
Researchers have identified the key enzyme causing Alzheimer’s disease by linking it to excessive GABA production in reactive astrocytes.
A study highlights that premature menopause significantly increases the risk of Type 2 diabetes, emphasizing the need for early detection.
A new review highlights the critical role of lncRNAs in the development, diagnosis, and treatment of acute kidney injury (AKI) and CKD.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Vail Scientific, in partnership with Minnetronix, has unveiled a newly designed VSNO sepsis screening device that enhances usability.